Cell death and survival (178 molecules) |
8.83E−11–7.5E−3
|
Cell death, apoptosis, cell survival |
NRAS, CYR61, EDN1, IL15, NRG1, LGALS3, PLAUR, LRIG1, CSF2, DKK1, DNAJA1, HIPK3, EMP2, THG1L, ILF3 |
Tissue development (104 molecules) |
2.4E−9–6.8E−3
|
Development of epithelial, endothelial tissues, endothelial cell development and proliferation, adhesion of epithelial cells, tubulation of epithelial tissue, detachment of cells |
NRAS, CYR61, EDN1, IL15, NRG1, LGALS3, PLAUR, CSF2, DKK1 |
Cellular growth and proliferation (174 molecules) |
2.75E−8–7.56E−3
|
Tumour and endothelial cell proliferation |
NRAS, CYR61, EDN1, IL15, NRG1, LGALS3, PLAUR, LRIG1, CSF2, DKK1, DNAJA1, MYCBP, PGK1, EMP2, THG1L, ILF3 |
Cardiovascular system development and function (84 molecules) |
3.71E−8–6.76E−3
|
Endothelial cell development and proliferation, development of blood vessels, cell movement of endothelial cells |
NRAS, CYR61, EDN1, IL15, NRG1, LGALS3, PLAUR, CSF2, DKK1, PGK1 |
Cellular development (150 molecules) |
5.8E−7–7.56E−3
|
Development of epithelial, endothelial cells |
NRAS, CYR61, EDN1, IL15, NRG1, LGALS3, PLAUR, LRIG1, CSF2, DKK1, MYCBP, PGK1 |
Organismal development (121 molecules) |
5.8E−7–7.97E−3
|
Development of endothelial cells and blood vessels |
NRAS, CYR61, EDN1, IL15, NRG1, LGALS3, PLAUR, LRIG1, CSF2, DKK1,DNAJA1, PGK1,ILF3 |
Cell-to-cell signalling and interaction (61 molecules) |
1.01E−6–7.84E−3
|
Adhesion of epithelial and endothelial cells |
NRAS, CYR61, EDN1, IL15, LGALS3, PLAUR, CSF2, DKK1 |
Cell morphology (119 molecules) |
1.82E−6–6.76E−3
|
Tubulation of cells |
NRAS, CYR61, EDN1, IL15, NRG1, LGALS3, PLAUR, CSF2, DNAJA1 |
Cellular movement (96 molecules) |
3.8E−5–7.99E−3
|
Tumour cell movement, invasion of cells, migration of tumour and endothelial cells |
NRAS, CYR61, EDN1, IL15, NRG1, LGALS3, PLAUR, LRIG1, CSF2, DKK1, DNAJA1 |